FDA Approves KarXT To Treat Schizophrenia; PureTech Health Gets $29 Mln Milestone Payment
This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb (BMS) in March of 2024. Royalty Pharma had acquired an interest in PureTech's royalty in KarXT.
PureTech Systems Inc., an established leader in geospatial AI-boosted video analytics for autonomous wide-area perimeter and ...
PureTech believes the results of the Phase 2b trial, together with a successful Phase 3 trial, could serve as the basis for registration in the U.S. and other geographies. LYT-100 (deupirfenidone ...
In a report released on September 27, Faisal Khurshid from Leerink Partners reiterated a Buy rating on PureTech Health (PRTC – Research ...
PureActiv will deploy across multiple locations to detect unauthorized access as ships travel through the waterway system.
Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech’s Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...
Only the top-spec Shine trim gets automatic gearbox variant with prices starting from Rs 10 lakh (Ex-sh). Buyers can also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback